drugset / Trial / NCT05347095
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and to assess the overall safety of guselkumab.
Timeline
- Start
- 2022-09-27
- Primary completion
- 2027-03-25
- Completion
- 2027-03-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guselkumab | Monoclonal antibody | — | Subcutaneous |